Recruiting

VATS

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT05583916

Conditions

Lung Cancer

Surgery

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung

Study Details

Brief summary:

Phase I to evaluate the safety and feasibility of same-day discharge in selected participants undergoing minimally-invasive lung surgery and who receive an enhanced recovery pathway.

Conditions

Lung Cancer

Surgery

Study ID

NCT05583916

Start date

Sep 7, 2022

Status verified date

Oct, 2022

Completion date

Oct, 2023

Anticipated

Primary completion date

Oct, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Signed or verbal informed consent by participant
  • Male and female adults, age 18 and above
  • Clinical stage I-II lung cancer (suspected, proven, unproven), or secondary pulmonary malignancy
  • BMI < 35
  • ECOG 0-1
  • Eligible for surgery and lung cancer resection (FEV1 > 60%, DLCO > 60%)
  • Elective VATS anatomic resection (segmentectomy or lobectomy), or wedge resection
  • Capable caregiver for discharge home

Exclusion Criteria:

  • Clinical stage III lung cancer
  • Surgery requiring pneumonectomy
  • Neoadjuvant therapy
  • Active pregnancy or breastfeeding
  • History of chronic pain syndromes
  • History of chronic opioid use
  • Concomitant major surgery indicated with current admission to hospital
  • Anticipated intraoperative complication including conversion to thoracotomy, major bleeding requiring blood transfusion, extensive adhesiolysis, injury to mediastinal structures, airway injury, nerve injury (phrenic, recurrent)
  • Need for epidural or patient-controlled intravenous analgesia
  • Need for urinary catheter

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

other: Lung Cancer Patients

Patients with stage I or II primary lung cancer or pulmonary metastasis scheduled to undergo surgery.

Interventions

Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung

All patients will be scheduled to surgery at the start of the day and will be discharged within the same day as the procedure.

Primary outcome measure

  • Adverse Event Rate [ Time Frame: 30 days post surgery ]
  • Same Day Discharge Rate [ Time Frame: Throughout the trial, from start until completion of surgery for all the patients, up to 12 months. ]
  • Readmission Rate [ Time Frame: 30 days post surgery ]
  • Rate of presentation to the emergency room after surgery [ Time Frame: 30 days post surgery ]

Central Contacts and Locations

Central contacts

Jonathan Spicer, MD, PhD

514-934-1934jonathan.spicer@mcgill.ca

Locations

McGill University Health Centre

Recruiting

Montreal, Quebec, Canada, H4A 3J1

More Information

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Last update posted

Oct 18, 2022

Last verified

Oct, 2022

Keywords

  • Same Day Discharge
  • Video-Assisted Thoracoscopic Surgery (VATS)
  • Minimally Invasive Surgery
  • Enhanced Recovery Pathway

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2022-10-18.